Rare diseases
Investigational molecules
Locations
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
ItalyStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
ItalyPhase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
ItalySafety Study of NB-4746 with Riluzole and Placebo in Adults with Amyotrophic Lateral Sclerosis (ALS)
ItalyPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
ItalyEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
ItalyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
ItalyBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
ItalyOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
ItalyLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
ItalyA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
ItalyA study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
